Immunohistochemical and in situ hybridization studies on glycine transporter 1 after transient ischemia in the rat forebrain

Neurochemistry International

Volumn 52, Issue 4-5, 2008, Pages 799-808

  Kalló, Imre ^a,c   Jekkel, Csilla ^a   Hrabovszky, Erik ^a   Jurányi, Zsolt ^b   Vida, Barbara ^a   Járási, Andrea ^b   Wilheim, Tamás ^a   Harsing Jr , Laszlo G ^b   Liposits, Zsolt ^a,c  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b EGIS PHARMACEUTICALS LTD   (Hungary)

^c PÁZMÁNY PÉTER CATHOLIC UNIVERSITY   (Hungary)

Author keywords

GLYT1 immunoreactivity; Ischemia; MCAO; Penumbra; Reperfusion

Indexed keywords

GLYCINE; GLYCINE TRANSPORTER 1; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN ISCHEMIA; CONTROLLED STUDY; CORPUS STRIATUM; DIENCEPHALON; GLIA CELL; GLOBUS PALLIDUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REPERFUSION INJURY; SOMATOSENSORY CORTEX; TELENCEPHALON;

ANIMALS; AUTORADIOGRAPHY; BLOTTING, WESTERN; CEREBRAL INFARCTION; DATA INTERPRETATION, STATISTICAL; GLYCINE PLASMA MEMBRANE TRANSPORT PROTEINS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; ISCHEMIC ATTACK, TRANSIENT; MALE; PROSENCEPHALON; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

ANIMALIA; RATTUS;

EID: 38349158641     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2007.09.011     Document Type: Article

References (59)

1. Alberati D., Hainzl D., Jolidon S., Krafft E.A., Kurt A., Maier A., Pinard E., Thomas A.W., and Zimmerli D. Discovery of 4-substituted-8-(2-hydroxy-2-phenyl-cyclohexyl)-2,8-diaza-spiro[4.5]decan-1-one as a novel class of highly selective GlyT1 inhibitors with improved metabolic stability. Bioorg. Med. Chem. Lett. 16 (2006) 4311-4315
2. Ata K.A., Lennmyr F., Funa K., Olsson Y., and Terent A. Expression of transforming growth factor-beta 1, 2, 3 isoforms and type I and II receptors in acute focal cerebral ischemia: an immunohistochemical study in rat after transient and permanent occlusion of middle cerebral artery. Acta Neuropathol. 97 (1999) 447-455
3. Baliova M., and Jursky F. Calpain sensitive regions in the N-terminal cytoplasmic domains of glycine transporters GlyT1A and GlyT1B. Neurochem. Res. 30 (2005) 1093-1100
4. Barnum S.R., Ames R.S., Maycox P.R., Hadingham S.J., Meakin J., Harrison D., and Parsons A.A. Expression of the complement C3a and C5a receptors after permanent focal ischemia: An alternative interpretation. Glia 38 (2002) 169-173
5. Betz H., Gomeza J., Armsen W., Scholze P., and Eulenburg V. Glycine transporters: essential regulators of synaptic transmission. Biochem. Soc. Trans. 34 (2006) 55-58
6. Chen J.C., Hsu-Chou H., Lu J.L., Chiang Y.C., Huang H.M., Wang H.L., Wu T., Liao J.J., and Yeh T.S. Down-regulation of the glial glutamate transporter GLT-1 in rat hippocampus and striatum and its modulation by a group III metabotropic glutamate receptor antagonist following transient global forebrain ischemia. Neuropharmacology 49 (2005) 703-714
7. Cubelos B., Gimenez C., and Zafra F. Localization of the GLYT1 glycine transporter at glutamatergic synapses in the rat brain. Cereb. Cortex 15 (2005) 448-459
8. Danysz W., and Parsons A.C. Glycine and N-methyl-d-aspartate receptors: physiological significance and possible therapeutic applications. Pharmacol. Rev. 50 (1998) 597-664
9. Depoortere R., Dargazanli G., Estenne-Bouhtou G., Coste A., Lanneau C., Desvignes C., Poncelet M., Heaulme M., Santucci V., Decobert M., Cudennec A., Voltz C., Boulay D., Terranova J.P., Stemmelin J., Roger P., Marabout B., Sevrin M., Vige X., Biton B., Steinberg R., Francon D., Alonso R., Avenet P., Oury-Donat F., Perrault G., Griebel G., George P., Soubrie P., and Scatton B. Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic. Neuropsychopharmacology 30 (2005) 1963-1985
10. Derouiche A., and Frotscher M. Peripheral astrocyte processes: monitoring by selective immunostaining for the actin-binding ERM proteins. Glia 36 (2001) 330-341
11. Dringen R., Verleysdonk S., Hamprecht B., Willker W., Leibfritz D., and Brand A. Metabolism of glycine in primary astroglial cells: synthesis of creatine, serine, and glutathione. J. Neurochem. 70 (1998) 835-840
12. Dronne M.A., Grenier E., Dumont T., Hommel M., and Boissel J.P. Role of astrocytes in grey matter during stroke: a modelling approach. Brain Res. 1138 (2007) 231-242
13. Gabernet L., Pauly-Evers M., Schwerdel C., Lentz M., Bluethmann H., Vogt K., Alberati D., Mohler H., and Boison D. Enhancement of the NMDA receptor function by reduction of glycine transporter-1 expression. Neurosci. Lett. 373 (2005) 79-84
14. Goldmuntz E.A., Brosnan C.F., Chiu F.C., and Norton W.T. Astrocytic reactivity and intermediate filament metabolism in experimental autoimmune encephalomyelitis: the effect of suppression with prazosin. Brain Res. 397 (1986) 16-26
15. Gomeza J., Zafra F., Olivares L., Gimenez C., and Aragon C. Regulation by phorbol esters of the glycine transporter (GLYT1) in glioblastoma cells. Biochim. Biophys. Acta 1233 (1995) 41-46
16. Hardingham G.E., Fukunaga Y., and Bading H. Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat. Neurosci. 5 (2002) 405-414
17. Harsing Jr. L.G., Gigler G., Moricz K., Agoston M., Marko B., Szabo G., Szenasi G., and Juranyi Zs. Anti-ischemic effects of ORG-24461 and NFPS, two glycine transporter type-1 inhibitors (2005), Society for Neuroscience, Washington (Abst. 669.16)
18. Harsing Jr. L.G., Juranyi Z., Gacsalyi I., Tapolcsanyi P., Czompa A., and Matyus P. Glycine transporter type-1 and its inhibitors. Curr. Med. Chem. 13 (2006) 1017-1044
19. Igartua I., Solis J.M., and Bustamante J. Glycine-induced long-term synaptic potentiation is mediated by the glycine transporter GLYT1. Neuropharmacology 52 (2007) 1586-1595
20. Johnson J.W., and Ascher P. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 325 (1987) 529-531
21. Jursky F., and Nelson N. Developmental expression of the glycine transporters GLYT1 and GLYT2 in mouse brain. J. Neurochem. 67 (1996) 336-344
22. Kallo I., Butler J.A., Barkovics-Kallo M., Goubillon M.L., and Coen C.W. Oestrogen receptor beta-immunoreactivity in gonadotropin releasing hormone-expressing neurones: regulation by oestrogen. J. Neuroendocrinol. 13 (2001) 741-748
23. Katsuki H., Watanabe Y., Fujimoto S., Kume T., and Akaike A. Contribution of endogenous glycine and d-serine to excitotoxic and ischemic cell death in rat cerebrocortical slice cultures. Life Sci. 81 (2007) 740-749
24. Kemp J.A., and Leeson P.D. The glycine site of the NMDA receptor five years on. Trends Pharmacol. Sci. 14 (1993) 20-25
25. Kim J.B., Piao C.S., Lee K.W., Han P.L., Ahn J.I., Lee Y.S., and Lee J.K. Delayed genomic responses to transient middle cerebral artery occlusion in the rat. J. Neurochem. 89 (2004) 1271-1282
26. Langosch D., Becker C.M., and Betz H. The inhibitory glycine receptor: a ligand-gated chloride channel of the central nervous system. Eur. J. Biochem. FEBS 194 (1990) 1-8
27. Lee W.H., and Bondy C.A. Ischemic injury induces brain glucose transporter gene expression. Endocrinology 133 (1993) 2540-2544
28. Li L., Lundkvist A., Andersson D., Wilhelmsson U., Nagai N., Pardo A.C., Nodin C., Stahlberg A., Aprico K., Larsson K., Yabe T., Moons L., Fotheringham A., Davies I., Carmeliet P., Schwartz J.P., Pekna M., Kubista M., Blomstrand F., Maragakis N., Nilsson M., and Pekny M. Protective role of reactive astrocytes in brain ischemia. J. Cereb. Blood Flow Metab. (2007) August 29, Epub ahead of print
29. Lipton P. Ischemic cell death in brain neurons. Physiol. Rev. 79 (1999) 1431-1568
30. Longa E.Z., Weinstein P.R., Carlson S., and Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke J. Cereb. Circ. 20 (1989) 84-91
31. Lowe J., Drozda S., Qian W., Peakman M.C., Liu J., Gibbs J., Harms J., Schmidt C., Fisher K., Strick C., Schmidt A., Vanase M., and Lebel L. A novel, non-substrate-based series of glycine type 1 transporter inhibitors derived from high-throughput screening. Bioorg. Med. Chem. Lett. 17 (2007) 1675-1678
32. Martina M., ME B.T., Halman S., Tsai G., Tiberi M., CoyleF J.T., and Bergeron R. Reduced glycine transporter type 1 expression leads to major changes in glutamatergic neurotransmission of CA1 hippocampal neurones in mice. J. Physiol. 563 (2005) 777-793
33. Matucz E., Moricz K., Gigler G., Simo A., Barkoczy J., Levay G., Harsing Jr. L.G., and Szenasi G. Reduction of cerebral infarct size by non-competitive AMPA antagonists in rats subjected to permanent and transient focal ischemia. Brain Res. 1019 (2004) 210-216
34. Nong Y., Huang Y.Q., Ju W., Kalia L.V., Ahmadian G., Wang Y.T., and Salter M.W. Glycine binding primes NMDA receptor internalization. Nature 422 (2003) 302-307
35. Oda M., Kure S., Sugawara T., Yamaguchi S., Kojima K., Shinka T., Sato K., Narisawa A., Aoki Y., Matsubara Y., Omae T., Mizoi K., and Kinouchi H. Direct correlation between ischemic injury and extracellular glycine concentration in mice with genetically altered activities of the glycine cleavage multienzyme system. Stroke J. Cereb. Circ. 38 (2007) 2157-2164
36. Papp A., Juranyi Z., Nagymajtenyi L., Matyus P., and Harsing Jr. L.G. The synaptic and nonsynaptic glycine transporter type-1 inhibitors Org-24461 and NFPS alter single neuron firing rate in the rat dorsal raphe nucleus Further evidence for a glutamatergic-serotonergic interaction and its role in antipsychotic action. Neurochem. Int. (2007) July 1, Epub ahead of print
37. Pearlman R.J., Aubrey K.R., and Vandenberg R.J. Arachidonic acid and anandamide have opposite modulatory actions at the glycine transporter, GLYT1a. J. Neurochem. 84 (2003) 592-601
38. Poyatos I., Ponce J., Aragon C., Gimenez C., and Zafra F. The glycine transporter GLYT2 is a reliable marker for glycine-immunoreactive neurons. Brain Res. 49 (1997) 63-70
39. Rahman S.S., Coulton S., Herdon H.J., Joiner G.F., Jin J., and Porter R.A. 1,3-diaminopropan-2-ol sulfonamides as potent and selective inhibitors of the glycine transporter type 1. Bioorg. Med. Chem. Lett. 17 (2007) 1741-1745
40. Rampon C., Luppi P.H., Fort P., Peyron C., and Jouvet M. Distribution of glycine-immunoreactive cell bodies and fibers in the rat brain. Neuroscience 75 (1996) 737-755
41. Rickhag M., Teilum M., and Wieloch T. Rapid and long-term induction of effector immediate early genes (BDNF, Neuritin and Arc) in peri-infarct cortex and dentate gyrus after ischemic injury in rat brain. Brain Res. 1151 (2007) 203-210
42. Rissanen A., Sivenius J., and Jolkkonen J. Prolonged bihemispheric alterations in unfolded protein response related gene expression after experimental stroke. Brain Res. 1087 (2006) 60-66
43. Ronnback A., Dahlqvist P., Svensson P.A., Jernas M., Carlsson B., Carlsson L.M., and Olsson T. Gene expression profiling of the rat hippocampus 1 month after focal cerebral ischemia followed by enriched environment. Neurosci. Lett. 385 (2005) 173-178
44. Roux M.J., and Supplisson S. Neuronal and glial glycine transporters have different stoichiometries. Neuron 25 (2000) 373-383
45. Sato K., Adams R., Betz H., and Schloss P. Modulation of a recombinant glycine transporter (GLYT1b) by activation of protein kinase C. J. Neurochem. 65 (1995) 1967-1973
46. Sonninen R., Virtanen T., Sivenius J., and Jolkkonen J. Gene expression profiling in the hippocampus of rats subjected to focal cerebral ischemia and enriched environment housing. Restor. Neurol. Neurosci. 24 (2006) 17-23
47. Sur C., and Kinney G.G. Glycine transporter 1 inhibitors and modulation of NMDA receptor-mediated excitatory neurotransmission. Curr. Drug Targets 8 (2007) 643-649
48. Takagaki Y., Itoh Y., Aoki Y., Ukai Y., Yoshikuni Y., and Kimura K. Inhibition of ischemia-induced fodrin breakdown by a novel phenylpyrimidine derivative NS-7: an implication for its neuroprotective action in rats with middle cerebral artery occlusion. J. Neurochem. 68 (1997) 2507-2513
49. Thoren A.E., Helps S.C., Nilsson M., and Sims N.R. Astrocytic function assessed from 1-14C-acetate metabolism after temporary focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 25 (2005) 440-450
50. Trapp T., Olah L., Holker I., Besselmann M., Tiesler C., Maeda K., and Hossmann K.A. GTPase RhoB: an early predictor of neuronal death after transient focal ischemia in mice. Mol. Cell. Neurosci. 17 (2001) 883-894
51. Vandenberg R.J., and Aubrey K.R. Glycine transport inhibitors as potential antipsychotic. Drugs 5 (2001) 507-518
52. Vandenberg R.J., Ju P., Aubrey K.R., Ryan R.M., and Mitrovic A.D. Allosteric modulation of neurotransmitter transporters at excitatory synapses. Eur. J. Pharm. Sci. 23 (2004) 1-11
53. Vandenberg R.J., Shaddick K., and Ju P. Molecular basis for substrate discrimination by glycine transporters. J. Biol. Chem. 282 (2007) 14447-14453
54. Westergren I., Nystrom B., Hamberger A., and Johansson B.B. Amino acids in extracellular fluid in vasogenic brain edema. Acta Neurochirurgica 60 (1994) 124-127
55. Yee B.K., Balic E., Singer P., Schwerdel C., Grampp T., Gabernet L., Knuesel I., Benke D., Feldon J., Mohler H., and Boison D. Disruption of glycine transporter 1 restricted to forebrain neurons is associated with a procognitive and antipsychotic phenotypic profile. J. Neurosci. 26 (2006) 3169-3181
56. Zafra F., Aragon C., Olivares L., Danbolt N.C., Gimenez C., and Storm-Mathisen J. Glycine transporters are differentially expressed among CNS cells. J. Neurosci. 15 (1995) 3952-3969
57. Zafra F., Gomeza J., Olivares L., Aragon C., and Gimenez C. Regional distribution and developmental variation of the glycine transporters GLYT1 and GLYT2 in the rat CNS. Eur. J. Neurosci. 7 (1995) 1342-1352
58. Zhang S.J., Steijaert M.N., Lau D., Schutz G., Delucinge-Vivier C., Descombes P., and Bading H. Decoding NMDA receptor signaling: identification of genomic programs specifying neuronal survival and death. Neuron 53 (2007) 549-562
59. Zhang Y., Park T.S., and Gidday J.M. Hypoxic preconditioning protects human brain endothelium from ischemic apoptosis by Akt-dependent survivin activation. Am. J. Physiol. 292 (2007) H2573-H2581